Published in J Pathol Bacteriol on October 01, 1965
Human vibriosis. Br Med J (1967) 0.75
Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58
Nonfermentative bacilli associated with man. 3. Pathogenicity and antibiotic susceptibility. Am J Clin Pathol (1970) 5.61
Characterization of saccharolytic nonfermentative bacteria associated with man. Can J Microbiol (1970) 5.07
Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc Natl Acad Sci U S A (1976) 3.57
Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. J Biol Chem (1983) 3.31
Rapid method for identification of gram-negative, nonfermentative bacilli. J Clin Microbiol (1976) 3.24
Separation and purification of the hemagglutinins from Bordetella pertussis. Infect Immun (1983) 2.85
Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infect Immun (1981) 2.77
Clinical isolation of Yersinia enterocolitica: cold temperature enrichment. J Clin Microbiol (1975) 2.76
Nonfermentative bacilli associated with man. II. Detection and identification. Am J Clin Pathol (1970) 2.69
Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis. Infect Immun (1988) 2.55
Salient features of nonsaccharolytic and weakly saccharolytic nonfermentative rods. Can J Microbiol (1970) 2.50
Salient features of Haemophilus vaginalis. J Clin Microbiol (1979) 2.40
ADP-ribosylation of transducin by pertussis toxin blocks the light-stimulated hydrolysis of GTP and cGMP in retinal photoreceptors. J Biol Chem (1984) 2.39
Heamophilus vaginalis (Corynebacterium vaginal): method for isolation and rapid biochemical identification. Health Lab Sci (1977) 2.37
Aerosol infection of mice with Bordetella pertussis. Infect Immun (1980) 2.31
Phase-shift markers in Bordetella: alterations in envelope proteins. J Infect Dis (1981) 2.23
Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect Immun (1986) 2.18
Recovery of Yersinia enterocolitica from streams and lakes of California. Appl Environ Microbiol (1976) 2.08
Detection, identification, and comparison of Capnocytophaga, Bacteroides ochraceus, and DF-1. J Clin Microbiol (1979) 2.02
Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice. J Infect Dis (1984) 1.96
Sensitivity and specificity of clinical case definitions for pertussis. Am J Public Health (1988) 1.93
Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies. Infect Immun (1988) 1.92
Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein. J Biol Chem (1988) 1.88
Intracellular localization of the dermonecrotic toxin of Bordetella pertussis. Infect Immun (1979) 1.83
Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun (1983) 1.77
Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis. Infect Immun (1988) 1.71
Immunologic response to early and routine DTP immunization in infants. Pediatrics (1984) 1.71
Binding of pertussis toxin to eucaryotic cells and glycoproteins. Infect Immun (1989) 1.71
Pertussis toxin substrate, the putative Ni component of adenylyl cyclases, is an alpha beta heterodimer regulated by guanine nucleotide and magnesium. Proc Natl Acad Sci U S A (1983) 1.67
Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. J Exp Med (1990) 1.67
Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation. Pediatrics (1988) 1.66
Ns and Ni, the stimulatory and inhibitory regulatory components of adenylyl cyclases. Purification of the human erythrocyte proteins without the use of activating regulatory ligands. J Biol Chem (1984) 1.62
Stimulation and inhibition of adenylyl cyclases mediated by distinct regulatory proteins. Nature (1983) 1.59
Methods for distinguishing gram-positive from gram-negative bacteria. J Clin Microbiol (1982) 1.57
Nonfermentative bacilli associated with man. I. Nomenclature. Am J Clin Pathol (1970) 1.57
Experimental Cholera in Chinchillas: the Immune Response in Serum and Intestinal Secretions to Vibrio cholerae and Cholera Toxin. Infect Immun (1974) 1.53
Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology. Infect Immun (1987) 1.52
Isolation of Brucella spp. from clinical specimens. J Clin Microbiol (1984) 1.52
Identification of oxidase-positive, glucose-negative, motile species of nonfermentative bacilli. J Clin Microbiol (1986) 1.51
Identification of Bordetella pertussis infection by shared-primer PCR. J Clin Microbiol (1994) 1.49
Purification and characterization of fimbriae isolated from Bordetella pertussis. Infect Immun (1985) 1.47
Monoclonal antibodies to pertussis toxin: utilization as probes of toxin function. Hybridoma (1989) 1.43
Experimental cholera in the chinchilla. J Infect Dis (1974) 1.38
A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. J Infect Dis (1988) 1.37
Structural characterization of pertussis toxin A subunit. J Biol Chem (1987) 1.36
Immune response to the B oligomer of pertussis toxin. Infect Immun (1987) 1.36
Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies. Infect Immun (1989) 1.32
Yersinia enterocolitica: in vitro antimicrobial susceptibility. Antimicrob Agents Chemother (1978) 1.30
Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies. Pediatr Infect Dis (1984) 1.25
Pertussis toxin inhibition of chemotaxis and the ADP-ribosylation of a membrane protein in a human-mouse hybrid cell line. Proc Natl Acad Sci U S A (1985) 1.24
Adenine nucleotides promote dissociation of pertussis toxin subunits. J Biol Chem (1986) 1.17
Cloning and sequencing of the structural gene for the porin protein of Bordetella pertussis. Mol Microbiol (1991) 1.13
In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor. Infect Immun (1984) 1.12
Biphasic effect of pertussis vaccine on serum insulin in mice. Infect Immun (1983) 1.11
Phase-shift markers in the genus Bordetella: loss of cytochrome d-629 in phase IV variants. Microbios (1981) 1.10
Stimulation of the thiol-dependent ADP-ribosyltransferase and NAD glycohydrolase activities of Bordetella pertussis toxin by adenine nucleotides, phospholipids, and detergents. Biochemistry (1986) 1.10
Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae. Infect Immun (1987) 1.10
Mechanism of pertussis toxin B oligomer-mediated protection against Bordetella pertussis respiratory infection. Infect Immun (1990) 1.08
Beta-galactosidase for distinguishing between Citrobacter and Salmonella. Appl Microbiol (1966) 1.07
Lymphocytosis-promoting factor of Bordetella pertussis alters mononuclear phagocyte circulation and response to inflammation. Infect Immun (1984) 1.07
Regulation of Bordetella pertussis extracytoplasmic adenylate cyclase. Adv Cyclic Nucleotide Res (1978) 1.06
Pertussis in a previously immunized child with human immunodeficiency virus infection. J Pediatr (1989) 1.05
Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. J Infect Dis (1991) 1.04
Reaction of Vibrio cholerae and choleragenic toxin in ileal loop of laboratory animals. J Bacteriol (1969) 1.04
The antigens of Mycobacterium tuberculosis. Protein fractions from cytoplasm and culture filtrate. Am Rev Respir Dis (1968) 1.03
Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen. Dev Biol Stand (1985) 1.02
A study of the Va-1 group of pseudomonads and its relationship to Pseudomonas pickettii. J Gen Microbiol (1980) 1.00
Pertussis vaccine research. Bull World Health Organ (1981) 0.99
Central venous catheter infection caused by Moraxella osloensis in a patient receiving home parenteral nutrition. Diagn Microbiol Infect Dis (1994) 0.99
Mechanisms in the vectorial receptor-adenylate cyclase signal transduction. Adv Cyclic Nucleotide Protein Phosphorylation Res (1984) 0.98
A protein activator for the adenylate cyclase of Bordetella pertussis. J Biol Chem (1979) 0.98
Adenyl cyclase in Bordetella pertussis vaccines. J Infect Dis (1977) 0.97
Delayed lactose fermentation by enterobacteriaceae. J Bacteriol (1966) 0.96
Proliferative response of immune mouse T-lymphocytes to the lymphocytosis-promoting factor of Bordetella pertussis. Infect Immun (1984) 0.95
Antigens of mycobacterial cell walls. Infect Immun (1970) 0.94
Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain. Pediatr Infect Dis J (1989) 0.94
Evaluation of a ribosomal vaccine against pertussis. Infect Immun (1979) 0.93
Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled. J Infect Dis (1988) 0.92
Selective breeding to establish a standard mouse for pertussis vaccine bioassay. II. Bioresponses of mice susceptible and resistant to sensitization by pertussis vaccine HSF. J Biol Stand (1975) 0.92
Pseudomonas vesicularis from cervical specimens. J Clin Microbiol (1978) 0.90
Radiobacteriolysis: a new technique using chromium-51 for assaying anti-Vibrio cholerae antibodies. Infect Immun (1973) 0.90
Immune response to dimeric subunits of the pertussis toxin B oligomer. Infect Immun (1989) 0.89
Immunogenicity and specificity of Listeria monocytogenes cell walls. J Infect Dis (1968) 0.89
Characterization of bacteria by their degradation of amino acids. Appl Microbiol (1968) 0.88
The current status of pertussis vaccine: an overview. Adv Appl Microbiol (1976) 0.88
Role of cysteine 41 of the A subunit of pertussis toxin. J Biol Chem (1989) 0.87
Antibodies to Bordetella pertussis in human colostrum and their protective activity against aerosol infection of mice. Infect Immun (1985) 0.87
Characterization of the filamentous hemagglutinin from Bordetella pertussis by gel electrophoresis. Mol Cell Biochem (1986) 0.87
Spurious protein activators of Bordetella pertussis adenylate cyclase. Eur J Biochem (1981) 0.86
Vibrio cholerae: production of toxin by a nonpathogenic strain. J Infect Dis (1970) 0.86
Assay of pertussis vaccine toxicity by a rat-paw-oedema method. J Med Microbiol (1977) 0.83
Effects of exogenous agents on the action of Bordetella parapertussis heat-labile toxin on guinea pig skin. Infect Immun (1990) 0.82
Involvement of filamentous hemagglutinin in the adherence of Bordetella pertussis to human WiDr cell cultures. Dev Biol Stand (1985) 0.82
Binding of ATP by pertussis toxin and isolated toxin subunits. Biochemistry (1990) 0.82
Deoxyribonuclease: detection with a three-hour test. J Clin Microbiol (1976) 0.81
Structural and functional properties of a 69-kilodalton outer membrane protein of Bordetella pertussis. Tokai J Exp Clin Med (1988) 0.81
Prospects for a new acellular pertussis vaccine. Ann Inst Pasteur Microbiol (1986) 0.81
Preliminary studies on the bioassay of anticholera vaccines in chinchillas. J Infect Dis (1970) 0.80